Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Carriage of the V279F null allele within the gene encoding Lp-PLA₂ is protective from coronary artery disease in South Korean males.

Jang Y, Waterworth D, Lee JE, Song K, Kim S, Kim HS, Park KW, Cho HJ, Oh IY, Park JE, Lee BS, Ku HJ, Shin DJ, Lee JH, Jee SH, Han BG, Jang HY, Cho EY, Vallance P, Whittaker J, Cardon L, Mooser V.

PLoS One. 2011 Apr 5;6(4):e18208. doi: 10.1371/journal.pone.0018208.

2.

Association between lipoprotein-associated phospholipase A2 gene polymorphism and coronary artery disease in the Chinese Han population.

Li L, Qi L, Lv N, Gao Q, Cheng Y, Wei Y, Ye J, Yan X, Dang A.

Ann Hum Genet. 2011 Sep;75(5):605-11. doi: 10.1111/j.1469-1809.2011.00666.x.

3.

Effects of V279F in the Lp-PLA(2) gene on markers of oxidative stress and inflammation in Koreans.

Paik JK, Chae JS, Jang Y, Kim JY, Kim OY, Jeong TS, Lee SH, Lee JH.

Clin Chim Acta. 2010 Apr 2;411(7-8):486-93. doi: 10.1016/j.cca.2009.12.021. Epub 2010 Jan 18.

PMID:
20080080
4.

The Val279Phe variant of the lipoprotein-associated phospholipase A2 gene is associated with catalytic activities and cardiovascular disease in Korean men.

Jang Y, Kim OY, Koh SJ, Chae JS, Ko YG, Kim JY, Cho H, Jeong TS, Lee WS, Ordovas JM, Lee JH.

J Clin Endocrinol Metab. 2006 Sep;91(9):3521-7. Epub 2006 Jun 20.

PMID:
16787988
5.

Effects of overweight and the PLA2G7 V279F polymorphism on the association of age with systolic blood pressure.

Kim M, Kim M, Yoo HJ, Jang HY, Lee SH, Lee JH.

PLoS One. 2017 Mar 23;12(3):e0173611. doi: 10.1371/journal.pone.0173611. eCollection 2017.

6.

Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study.

Hou L, Chen S, Yu H, Lu X, Chen J, Wang L, Huang J, Fan Z, Gu D.

Hum Genet. 2009 Feb;125(1):11-20. doi: 10.1007/s00439-008-0587-4. Epub 2008 Nov 26.

PMID:
19034521
7.

Translational studies of lipoprotein-associated phospholipase A₂ in inflammation and atherosclerosis.

Ferguson JF, Hinkle CC, Mehta NN, Bagheri R, Derohannessian SL, Shah R, Mucksavage MI, Bradfield JP, Hakonarson H, Wang X, Master SR, Rader DJ, Li M, Reilly MP.

J Am Coll Cardiol. 2012 Feb 21;59(8):764-72. doi: 10.1016/j.jacc.2011.11.019.

8.

Effects of A379V variant of the Lp-PLA 2 gene on Lp-PLA 2 activity and markers of oxidative stress and endothelial function in Koreans.

Chae JS, Kwak JH, Kim M, Shin KH, Lee SH, Jeong TS, Lee JH.

J Thromb Thrombolysis. 2014 Nov;38(4):477-84. doi: 10.1007/s11239-014-1074-5.

PMID:
24682749
9.

A phenome-wide association study of a lipoprotein-associated phospholipase A2 loss-of-function variant in 90 000 Chinese adults.

Millwood IY, Bennett DA, Walters RG, Clarke R, Waterworth D, Johnson T, Chen Y, Yang L, Guo Y, Bian Z, Hacker A, Yeo A, Parish S, Hill MR, Chissoe S, Peto R, Cardon L, Collins R, Li L, Chen Z; China Kadoorie Biobank Collaborative Group.

Int J Epidemiol. 2016 Oct;45(5):1588-1599. Epub 2016 Jun 14.

10.

Correlations Between LP-PLA2 Gene Polymorphisms and Susceptibility and Severity of Acute Pancreatitis in a Chinese Population.

Ma M, Zhai CX, Sun CX.

Genet Test Mol Biomarkers. 2017 Apr;21(4):206-212. doi: 10.1089/gtmb.2016.0243. Epub 2017 Mar 23.

PMID:
28332853
11.

Lipoprotein-associated phospholipase A2 activity is associated with coronary artery disease and markers of oxidative stress: a case-control study.

Kim JY, Hyun YJ, Jang Y, Lee BK, Chae JS, Kim SE, Yeo HY, Jeong TS, Jeon DW, Lee JH.

Am J Clin Nutr. 2008 Sep;88(3):630-7.

PMID:
18779277
12.

Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians.

Anuurad E, Ozturk Z, Enkhmaa B, Pearson TA, Berglund L.

J Clin Endocrinol Metab. 2010 May;95(5):2376-83. doi: 10.1210/jc.2009-2498. Epub 2010 Mar 1.

13.

Association of PLA2G7 gene polymorphisms with ischemic stroke in northern Chinese Han population.

Liu X, Zhu RX, Tian YL, Li Q, Li L, Deng SM, He ZY.

Clin Biochem. 2014 Apr;47(6):404-8. doi: 10.1016/j.clinbiochem.2014.01.010. Epub 2014 Jan 21.

PMID:
24463064
14.

Nonsynonymous polymorphisms in PLA2G7 gene are associated with the risk of coronary heart disease in a southern Chinese population.

Hong M, Zhang M, Lu X.

Mamm Genome. 2015 Apr;26(3-4):191-9. doi: 10.1007/s00335-015-9559-x. Epub 2015 Feb 18.

PMID:
25690150
15.

Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up.

Rallidis LS, Tellis CC, Lekakis J, Rizos I, Varounis C, Charalampopoulos A, Zolindaki M, Dagres N, Anastasiou-Nana M, Tselepis AD.

J Am Coll Cardiol. 2012 Nov 13;60(20):2053-60. doi: 10.1016/j.jacc.2012.06.057. Epub 2012 Oct 17.

16.

Lipoprotein-associated phospholipase A2 gene V279F polymorphisms and coronary heart disease: a meta-analysis.

Zheng GH, Chen HY, Xiong SQ, Chu JF.

Mol Biol Rep. 2011 Aug;38(6):4089-99. doi: 10.1007/s11033-010-0529-9. Epub 2010 Nov 24.

PMID:
21107710
17.

Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles.

Gregson JM, Freitag DF, Surendran P, Stitziel NO, Chowdhury R, Burgess S, Kaptoge S, Gao P, Staley JR, Willeit P, Nielsen SF, Caslake M, Trompet S, Polfus LM, Kuulasmaa K, Kontto J, Perola M, Blankenberg S, Veronesi G, Gianfagna F, Männistö S, Kimura A, Lin H, Reilly DF, Gorski M, Mijatovic V; CKDGen consortium, Munroe PB, Ehret GB; International Consortium for Blood Pressure, Thompson A, Uria-Nickelsen M, Malarstig A, Dehghan A; CHARGE inflammation working group, Vogt TF, Sasaoka T, Takeuchi F, Kato N, Yamada Y, Kee F, Müller-Nurasyid M, Ferrières J, Arveiler D, Amouyel P, Salomaa V, Boerwinkle E, Thompson SG, Ford I, Wouter Jukema J, Sattar N, Packard CJ, Shafi Majumder AA, Alam DS, Deloukas P, Schunkert H, Samani NJ, Kathiresan S; MICAD Exome consortium, Nordestgaard BG, Saleheen D, Howson JM, Di Angelantonio E, Butterworth AS, Danesh J; EPIC-CVD consortium and the CHD Exome+ consortium.

Eur J Prev Cardiol. 2017 Mar;24(5):492-504. doi: 10.1177/2047487316682186. Epub 2016 Dec 8. Review.

18.

Lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms and cardiovascular events in patients with coronary artery disease.

Maiolino G, Lenzini L, Pedon L, Cesari M, Seccia TM, Frigo AC, Rossitto G, Caroccia B, Rossi GP.

J Cardiovasc Med (Hagerstown). 2015 Jan;16(1):29-36. doi: 10.2459/JCM.0000000000000057. Erratum in: J Cardiovasc Med (Hagerstown). 2015 Mar;16(3):259.

PMID:
24732951
19.

T-786C polymorphism in the endothelial nitric oxide synthase gene is associated with increased risk of coronary artery disease in a Chinese population.

Han Y, Xu W, Zhang W, Liu N, Ji Y.

Pharmacology. 2010;85(4):211-6. doi: 10.1159/000275135. Epub 2010 Mar 6.

PMID:
20215811
20.

279(Val→Phe) Polymorphism of lipoprotein-associated phospholipase A(2) resulted in changes of folding kinetics and recognition to substrate.

Masbuchin AN, Rohman MS, Putri JF, Cahyaningtyas M, Widodo.

Comput Biol Chem. 2015 Dec;59 Pt A:199-207. doi: 10.1016/j.compbiolchem.2015.10.001. Epub 2015 Oct 19.

PMID:
26595893

Supplemental Content

Support Center